We are live on ! Find out more
PROF

Profound Medical

45 hedge funds and large institutions have $124M invested in Profound Medical in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 5

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

56% more capital invested

Capital invested by funds: $79.2M → $124M (+$44.4M)

32% more funds holding

Funds holding: 3445 (+11)

29% more call options, than puts

Call options by funds: $1.42M | Put options by funds: $1.1M

7.36% more ownership

Funds ownership: 28.98%36.34% (+7.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
45
Holders Change
+11
Holders Change %
+32.35%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
20
Reduced
5
Closed
5
Calls
$1.42M
Puts
$1.1M
Net Calls
+$319K
Net Calls Change
-$3.13M
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity International
1
Fidelity International
Bermuda
$19.8M +$3.65M +229,950 +26%
RG
2
Redmile Group
California
$14.6M +$6.75M +425,000 +106%
PVI
3
Pura Vida Investments
New York
$13.8M +$3.29M +207,011 +36%
GS
4
Gagnon Securities
New York
$13.8M +$760K +47,818 +7%
DM
5
Deerfield Management
New York
$12.3M +$11M +695,000 New
PWAM
6
Park West Asset Management
California
$7.94M +$7.15M +450,000 New
AIC
7
AWM Investment Company
New York
$6.16M
GA
8
Gagnon Advisors
New York
$4.89M +$325K +20,439 +8%
RI
9
RTW Investments
New York
$4.31M +$1.11M +70,000 +40%
BC
10
Blackcrane Capital
Washington
$3.47M +$344K +21,623 +12%
TWMP
11
Taylor Wealth Management Partners
Massachusetts
$2.94M +$857K +53,937 +48%
Renaissance Technologies
12
Renaissance Technologies
New York
$2.4M +$370K +23,300 +21%
GGHC
13
Gilder Gagnon Howe & Co
New York
$2.36M +$2.13M +133,931 New
PIC
14
PCJ Investment Counsel
Ontario, Canada
$2.14M +$468K +29,440 +32%
ZDA
15
Zweig-DiMenna Associates
New York
$2.08M -$1.1M -69,000 -37%
PHP
16
Parkman Healthcare Partners
Connecticut
$1.24M +$1.11M +70,000 New
Bank of America
17
Bank of America
North Carolina
$1.15M +$399K +25,118 +62%
Bank of Montreal
18
Bank of Montreal
Ontario, Canada
$1.02M +$660K +41,517 +210%
LBA
19
Letko, Brosseau & Associates
Quebec, Canada
$811K +$731K +46,000 New
BCM
20
Barometer Capital Management
Ontario, Canada
$792K -$221K -13,900 -29%
Two Sigma Investments
21
Two Sigma Investments
New York
$753K +$679K +42,708 New
RJFSA
22
Raymond James Financial Services Advisors
Florida
$751K +$498K +31,365 +277%
Morgan Stanley
23
Morgan Stanley
New York
$713K +$448K +28,221 +232%
Two Sigma Advisers
24
Two Sigma Advisers
New York
$543K +$181K +11,400 +59%
CIC
25
Chilton Investment Company
Connecticut
$529K

PROF Hedge Fund Activity: Q3 2020 in Review

45 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q3 2020, worth a combined $124M — up 56% from $79.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new PROF positions and 5 closed out — a net gain of 11 holders — while 20 added to existing stakes and 5 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $11M. The largest seller was Royce & Associates, cutting an estimated $4.5M.

  • 45 institutional investors held Profound Medical (PROF) as of Q3 2020, up from 34 in Q2 2020.
  • Funds reported $124M of Profound Medical stock for Q3 2020, up 56% quarter-over-quarter.
  • 16 funds opened new Profound Medical positions in Q3 2020 and 5 closed out, a net change of +11 holders.
  • The largest Profound Medical buyer in Q3 2020 was Deerfield Management, an estimated $11M added.
  • The largest Profound Medical seller in Q3 2020 was Royce & Associates, an estimated $4.5M sold.

Based on aggregated 13F filings for Q3 2020.